Search - tctmd.com

Displaying 361 - 380 of 478

Sort: Relevancy | Date

News Daily News

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Caitlin E. Cox

April 28, 2017

Presentation

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

April 25, 2017

News Daily News

Long-term MI Risk Among Stable CAD Patients: Some Clues From CORONOR

Shelley Wood

April 24, 2017

News Daily News

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Michael O'Riordan

April 18, 2017

Presentation

Economic Outcomes of Absorb BVSvs Everolimus-Eluting Stents in PCI

April 18, 2017

News Opinion Fellow Talk

The Left Main Debate: What Does it Mean for the Future of Intervention?

Tiffany Patterson, MBBS

April 12, 2017

Presentation Fellows 2017

Stent Thrombosis and Restenosis

Presenter: Emmanouil S. Brilakis, Ajay J. Kirtane

April 08, 2017

Presentation Fellows 2017

Bioresorbable Stent Technology: The Next Frontier?

Presenter: Ajay J. Kirtane, Gregg W. Stone

April 07, 2017

Presentation Fellows 2017

The Evolution of Drug-Eluting Stents

Presenter: Ajay J. Kirtane

April 07, 2017

News Daily News

Same-Day Discharge After Elective PCI Grows More Popular but Still Not the Norm

Caitlin E. Cox

April 06, 2017

News Daily News

Absorb BVS Use Restricted in Europe

Michael O'Riordan

April 06, 2017

News Industry News

REVA Receives CE Mark for Fantom

April 04, 2017

News Industry News

Eurocor announces the completion of the Freeway Stent Study

April 04, 2017

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

News Industry News

REVA to Expand FANTOM II Trial to More Complex Cases

March 24, 2017

Presentation CHIP Washington DC 2017

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Presenter: Gregg W. Stone

March 21, 2017

Presentation ACC 2017

Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results

Presenter: Stephen G. Ellis

March 19, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

Advertisement

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

Long-term MI Risk Among Stable CAD Patients: Some Clues From CORONOR

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Economic Outcomes of Absorb BVSvs Everolimus-Eluting Stents in PCI

The Left Main Debate: What Does it Mean for the Future of Intervention?

Stent Thrombosis and Restenosis

Bioresorbable Stent Technology: The Next Frontier?

The Evolution of Drug-Eluting Stents

Same-Day Discharge After Elective PCI Grows More Popular but Still Not the Norm

Absorb BVS Use Restricted in Europe

REVA Receives CE Mark for Fantom

Eurocor announces the completion of the Freeway Stent Study

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

REVA to Expand FANTOM II Trial to More Complex Cases

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content